Economic Outcomes Related to Persistence and Dosing of Celecoxib in Patients with Osteoarthritis (OA) Using a Retrospective Claims Database Analysis

OBJECTIVE: This study describes treatment patterns, healthcare resource utilization (HCRU), and costs associated with persistence, switching, and dosing of branded celecoxib in osteoarthritis (OA) patients. METHODS: This retrospective claims database analysis used MarketScan(®) Commercial Claims and...

Descripción completa

Detalles Bibliográficos
Autores principales: Johnson, Courtney, Stephens, Jennifer, Walker, Christopher, Cappelleri, Joseph C, Shelbaya, Ahmed
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982435/
https://www.ncbi.nlm.nih.gov/pubmed/32021340
http://dx.doi.org/10.2147/CEOR.S199145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982435/
https://www.ncbi.nlm.nih.gov/pubmed/32021340
http://dx.doi.org/10.2147/CEOR.S199145

Ejemplares similares